Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HRTX
#3001
Heron Therapeutics, Inc.
1.1
9
-0.83%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.83%
Monthly Change
-14.39%
6 month change
-11.85%
Year Change
-39.90%
Previous Close
1.2
0
Open
1.1
9
Bid
Ask
Low
1.1
9
High
1.1
9
Volume
58
Markets
US Stock Market
Healthcare
HRTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript
Heron Therapeuti earnings missed, revenue topped estimates
Heron Q4 2025 slides: acute care surge drives 48% ZYNRELEF growth
Heron Therapeutics stock soars after strong Q4 revenue growth
Heron’s APONVIE featured in new postoperative nausea guidelines
Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline
Heron Therapeutics, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HRTX) 2025-11-04
Heron Therapeutics Q3 2025 slides: strong product growth despite earnings miss
Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
Heron Therapeutics shareholders approve convertible securities issuances
Heron Therapeutics adopts tax benefits plan to protect $1.37 billion in NOLs